Moreover, the expression of IL-1β and TNF-α was significantly suppressed by supplementation with both fractions (p < 0.05), whereas IL-10 expression was significantly enhanced by AD supplementation (p < 0.05). This evidence concerns the gene IL10 and Alzheimer disease.